EWA
ZOM

EverSource Wealth Advisors’s Zomedica Corp. ZOM Stock Holding History

EverSource Wealth Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$100 Buy
+1,000
New +$100 ﹤0.01% 4307
2026
Q1 		– Sell
-10
Closed -$1 – 4527
2025
Q4 		$1 Buy
+10
New +$1 ﹤0.01% 4267
2023
Q1 		– Sell
-300
Closed -$49 – 2599
2022
Q4 		$49 Hold
300
– – ﹤0.01% 2283
2022
Q3 		$0 Hold
300
– – ﹤0.01% 2213
2022
Q2 		$0 Buy
+300
New +$76 ﹤0.01% 1959

Other funds holding ZOM

AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
GCP
Gill Capital Partners Denver, Colorado $378M AUM 18.32% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
BWL
Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

EverSource Wealth Advisors's ZOM Position: Q2 2026 in Review

EverSource Wealth Advisors opened a new position in Zomedica Corp. (ZOM) in Q2 2026: 1,000 shares worth $100. The stake represents ﹤0.01% of the portfolio and ranks #4307 among its holdings. This is a return to the name: EverSource Wealth Advisors previously reported a position in ZOM as recently as Q4 2025.

EverSource Wealth Advisors first reported a position in ZOM in Q2 2022 and has held it in 5 quarters since. 7 funds tracked by Wall St. Rank hold ZOM as of Q2 2026.

  • EverSource Wealth Advisors held 1,000 shares of Zomedica Corp. worth $100 as of Q2 2026.
  • Zomedica Corp. was a new EverSource Wealth Advisors position in Q2 2026.
  • Zomedica Corp. made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #4307 holding.
  • EverSource Wealth Advisors first reported a position in Zomedica Corp. in Q2 2022 and has held it in 5 quarters since.
  • 7 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.